PAMCX
Price
$96.01
Change
+$0.40 (+0.42%)
Updated
Jul 3 closing price
Net Assets
28B
STMGX
Price
$33.28
Change
+$0.31 (+0.94%)
Updated
Jul 3 closing price
Net Assets
663.43M
Interact to see
Advertisement

PAMCX vs STMGX

Header iconPAMCX vs STMGX Comparison
Open Charts PAMCX vs STMGXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$96.01
Change+$0.40 (+0.42%)
VolumeN/A
Net Assets28B
American Beacon Stephens Mid-Cap Gr I
Price$33.28
Change+$0.31 (+0.94%)
VolumeN/A
Net Assets663.43M
PAMCX vs STMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PAMCX vs. STMGX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a StrongBuy and STMGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 28B vs. STMGX (663M). PAMCX (0.00) and STMGX (0.00) have matching dividends . PAMCX was incepted earlier than STMGX: PAMCX (25 years) vs STMGX (19 years). STMGX (1.22) is less costly to investors than PAMCX (1.01). STMGX is a more actively managed with annual turnover of: 24.00 vs. PAMCX (22.60). PAMCX (2500) and STMGX (2500) have matching initial minimum investment requirements. STMGX annual gain was more profitable for investors over the last year : 12.74 vs. PAMCX (-2.05). STMGX return over 5 years is better than : 32.96 vs. PAMCX (5.54).
PAMCXSTMGXPAMCX / STMGX
Total Expense Ratio1.011.1687%
Annual Report Gross Expense Ratio1.011.2283%
Fund Existence25 years19 years-
Gain YTD2.1829.54623%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets28B663M4,223%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.0512.74-16%
Returns for 3 years13.7046.5429%
Returns for 5 years5.5432.9617%
Returns for 10 years20.7484.9824%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGC22.9912.63
+121.91%
Regencell Bioscience Holdings Limited
RVMD37.870.68
+1.83%
Revolution Medicines
GPRO0.74N/A
+0.65%
GoPro
GLP52.670.26
+0.50%
Global Partners LP
MNDR1.11N/A
N/A
Mobile-health Network Solutions